{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["von Witzleben A"],"funding":["Cancer Research UK","Deutsche Forschungsgemeinschaft","Medical Research Council","Biotechnology and Biological Sciences Research Council"],"pagination":["591063"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7871909"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["10"],"pubmed_abstract":["<h4>Introduction</h4>Human papillomavirus 16 (HPV16) is the main cause of oropharyngeal squamous cell carcinoma (OPSCC). To date, the links between HPV16 gene expression and adaptive immune responses have not been investigated. We evaluated the correlation of HPV16 DNA, RNA transcripts and features of adaptive immune response by evaluating antibody isotypes against E2, E7 antigens and density of tumor-infiltrating lymphocytes (TIL).<h4>Material and methods</h4>FFPE-tissue from 27/77 p16-positive OPSCC patients was available. DNA and RNA were extracted and quantified using qPCR for all HPV16 genes. The TIL status was assessed. Immune responses against E2 and E7 were quantified by ELISA (IgG, IgA, and IgM; 77 serum samples pre-treatment, 36 matched post-treatment).<h4>Results</h4>Amounts of "],"journal":["Frontiers in oncology"],"pubmed_title":["Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC."],"pmcid":["PMC7871909"],"funding_grant_id":["MR/K001744/1","# WI 5255/1-1:1, GRK-2254","BB/J004243/1","21998"],"pubmed_authors":["Akinyegun O","Thomas GJ","Bendjama K","von Witzleben A","King EV","Wood O","Chudley L","Thomas J","Friedmann PS","Ottensmeier CH","Currall E","Laban S"],"additional_accession":[]},"is_claimable":false,"name":"Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC.","description":"<h4>Introduction</h4>Human papillomavirus 16 (HPV16) is the main cause of oropharyngeal squamous cell carcinoma (OPSCC). To date, the links between HPV16 gene expression and adaptive immune responses have not been investigated. We evaluated the correlation of HPV16 DNA, RNA transcripts and features of adaptive immune response by evaluating antibody isotypes against E2, E7 antigens and density of tumor-infiltrating lymphocytes (TIL).<h4>Material and methods</h4>FFPE-tissue from 27/77 p16-positive OPSCC patients was available. DNA and RNA were extracted and quantified using qPCR for all HPV16 genes. The TIL status was assessed. Immune responses against E2 and E7 were quantified by ELISA (IgG, IgA, and IgM; 77 serum samples pre-treatment, 36 matched post-treatment).<h4>Results</h4>Amounts of ","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020","modification":"2026-05-01T12:44:49.5Z","creation":"2025-02-19T04:53:42.878Z"},"accession":"S-EPMC7871909","cross_references":{"pubmed":["33575210"],"doi":["10.3389/fonc.2020.591063"]}}